USCAP Sponsored Fellowship Fair
March 8, 2009

John B. Haynes Convention Center
Boston, MA (see Chris Iacobuzio for details of time and location)

Johns Hopkins Pathology Alumni Reception
March 9, 2009, 5:30 pm - 7:30 pm

Sheraton Boston Hotel, Commonwealth
Boston, MA

Monday, March 9, 2009 - 2:00 p.m. - 4:00 p.m.


Massimo Loda, MD
Director, Center for Molecular Pathology, Professor of Pathology & Medical Oncology
Brigham and Women's Hospital and Dana Farber Cancer Institute
Harvard Medical School
Boston, MA

David Berman, MD, PhD
Associate Professor of Pathology, Urology, and Oncology
Johns Hopkins University School of Medicine
Baltimore, MD

Course Description

This course is designed to enhance career development of clinically trained individuals considering a career in investigative pathology. We have arranged for a special discounted fee for admission. Since the course content is directed toward residents, fellows and junior faculty, CME credit will not be available. Space is limited, so early registration is encouraged.

Opportunities in pathology investigation have never been better. Recent developments in information technology, the sequencing of the human genome, and the advent of rational/targeted drug design put the pathologist at the center of a revolution in the classification and treatment of disease. These changes will take shape over the next few years in unfamiliar territory as collaborations between academia and industry. This course, designed for residents, fellows, and junior faculty, will present vignettes from the careers of successful investigative pathologists, along with their visions of current and future opportunities to in the field. Participants will be encouraged to ask questions of the panelists during an interactive panel discussion and after the course through an electronic message board.

Course Objectives:

  • To provide real-life examples of successful academic and industrial career trajectories in investigative pathology.
  • To explore different forms of academic-industrial collaborations in disease research.
  • To discuss practical ways to address issues with special relevance to pathology research, including:
    1. Choosing an investigative focus
    2. Getting the most from research collaborations
    3. Balancing service responsibilities with research
    4. Funding sources for research
    5. Career pathways for pathologists in academia and industry
  • To create a forum for ongoing discussion of career development strategies in pathology investigation.

Introduction - Drs. Massimoto Loda and David Berman


  • Marcus Bosenberg, MD, PhD - Associate Professor of Dermatology and Pathology, Yale School of Medicine, New Haven, CT
  • Beth Thurberg, MD, PhD - Vice President of Pathology, Genzyme Corporation, Framingham, MA
  • Resident or Fellow to be selected from Pathobiology abstract submissions
  • Giulio Draetta, MD - Vice President and Worldwide Franchise Head of Oncology, Merck Research Laboratories, Rahway, NJ
  • Christopher Fletcher FRCPath, MBBS, MD - Director of Surgical Pathology, Brigham and Women's Hospital, Professor of Pathology, Harvard Medical School, Boston, MA
  • Questions from audience and panel discussion


53. The Most Common GI Consultation Cases: An Audience-Directed Discussion

Friday Morning - March 13, 8:00 AM - 11:30 AM

Henry D. Appelman, M.D., University of Michigan, Ann Arbor, MI and Elizabeth A. Montgomery, M.D., Johns Hopkins Medical Institutions, Baltimore, MD

Gastrointestinal biopsies constitute a major part of the practice of most surgical pathologists. Many GI biopsies are straightforward, but there are cases that regularly present diagnostic challenges and are sent to specialized gastrointestinal pathologists for consultation. This course is designed to address precisely those cases. Common GI consultation cases sent to the University of Michigan and Johns Hopkins Medical Institutions were selected for discussion. These cases include Barrett's esophagus and ulcerative colitis surveillance biopsies, the colorectal adenoma that may or may not have a focus of invasive carcinoma, gastrointestinal spindle cell lesions, appendiceal mucinous and endocrine neoplasms, problematic biopsies from the ampulla of Vater, needle biopsies of masses in the liver, colitis that is difficult to classify, serrated polyps of the colon, and unusual patterns of pancreatitis.

Each case will be presented from the perspective of the submitting pathologist and from the perspective of the consultant GI pathologist. Then the audience will be presented with a selection of several possible discussions. Based on the audience response, one or more discussions will ensue. Pre-registrants will receive a website address where they can view case histories and images prior to the meeting. A syllabus will be distributed at the course. The entire course, including all of the optional discussions, will be available on the CD-ROM that will be mailed to registrants after the meeting.

The course is designed for advanced residents and practicing pathologists in any practice setting. Upon completion of the course, participants will be able to use the strategies discussed to better handle the types of cases presented. In addition, registrants will have an updated perspective on the key issues to be addressed in biopsies from patients with these diseases. This course may be used for CME credits or SAM's credit>s.


48. Surface Epithelial Neoplasms of the Ovary: New Concepts of Pathogenesis, Diagnostic Criteria, and Persistent Controversies, with an Emphasis on "Borderline" Tumors

Thursday Afternoon - March 12, 1:00 PM - 4:30 PM

Robert J. Kurman, M.D., Brigitte M. Ronnett, M.D., and Russell Vang, M.D., The Johns Hopkins Hospital, Baltimore, MD

This course will focus primarily on practical diagnostic issues concerning surface epithelial tumors of the ovary, with an emphasis on borderline tumors The following topics will be addressed in detail: 1) serous neoplasms: distinction of borderline tumors and low-grade and high-grade carcinomas, distinction of non-invasive from invasive implants, and new concepts of pathogenesis and nomenclature; 2) mucinous neoplasms: diagnostic criteria, distinction of primary ovarian tumors from metastases with use of ancillary techniques (immunohistochemistry); and 3) endometrioid, clear cell, and transitional cell neoplasms: diagnostic criteria and differential diagnosis.

At the end of the course, registrants should be able to: 1) understand modern ideas of pathogenesis of ovarian surface epithelial neoplasms, with an emphasis on the relationship between borderline tumors and carcinomas and their biologic behavior; 2) discuss diagnostic criteria and differential diagnosis for ovarian surface epithelial tumors, with an emphasis on distinction of borderline tumors and their variants from low-grade and high-grade carcinomas; and 3) discuss consensus points and persistent controversies regarding nomenclature, diagnosis, and behavior of borderline tumors.

This course is intended for practicing surgical pathologists, including those with an interest in gynecologic pathology. Pre-registrants will receive a website address where they can view digital images and clinical histories in advance for cases to be discussed. A syllabus will be distributed at the course, and a CD will be mailed to all registrants after the meeting. This course may be used for CME credits or SAM's credits.


60. Pancreatic Tumors, an Integrated Cyto-histopathologic Approach Mostafa Fraig, M.D., Johns Hopkins Bayview Medical Center, Baltimore, MD and David Lewin, M.D., Medical University of South Carolina, Charleston, SC

Friday Morning - March 13, 8:00 AM - 11:30 AM

This course covers practical issues regarding common pancreatic tumors and related lesions that face pathologists in their daily practice. The course will emphasize the integration of clinical and radiological findings into the differential diagnosis. Triage of specimen procurement for cytologic evaluation as well as issues related to intra-operative consultations and final diagnosis of the surgical specimens will be discussed. Diagnostic as well as therapeutic implications of certain findings or pitfalls will be addressed. The course will include a series of clinical scenarios with the pertinent algorithms applied in obtaining and evaluating cytologic material up to the point of rendering the final diagnosis on the surgical specimen.

This course is designed for the general pathologists and pathologists in training as well as subspecialists in cytopathology and GI pathology who are interested in following proper steps in evaluating pancreatic lesions whether cytologically or histologically.

Pre-registrants will receive a website address where they can view digital images and the pertinent clinical history for each case prior to the course. There will be a discussion and interaction among participants and the course directors. At the course, the participants will be provided with a comprehensive syllabus. After the meeting registrants will be mailed a CD-ROM with representative images.

Upon completion of this course the participants would be able to: 1) Accurately diagnose pancreatic lesions cytologically and histologically based on objective and validated criteria; 2) Recognize the helpful clinical and radiological findings and integrate them to resolve the differential diagnosis; 3) Understand the implications of certain cytologic and histologic findings in the diagnosis, therapy and prognosis of pancreatic lesions. This course may be used for CME credits or SAM's credits.


Back to top